Pharmacotherapy to reducevisceral fat
- 1 January 2005
- journal article
- Published by Elsevier in Clinical Cornerstone
- Vol. 7 (2-3) , 52-60
- https://doi.org/10.1016/s1098-3597(05)80068-7
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Circulating Adiponectin Levels Are Associated with Better Glycemic Control, More Favorable Lipid Profile, and Reduced Inflammation in Women with Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2005
- Race-ethnicity–specific waist circumference cutoffs for identifying cardiovascular disease risk factors1–3The American Journal of Clinical Nutrition, 2005
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Waist circumference and not body mass index explains obesity-related health riskThe American Journal of Clinical Nutrition, 2004
- Energy Homeostasis, Obesity and Eating Disorders: Recent Advances in EndocrinologyJournal of Nutrition, 2004
- Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and AtherosclerosisEndocrinology, 2003
- Treatment of obesity: need to focus on high risk abdominally obese patientsBMJ, 2001
- Health consequences of visceral obesityAnnals of Medicine, 2001
- Body-Mass Index and Mortality in a Prospective Cohort of U.S. AdultsNew England Journal of Medicine, 1999
- Development of the multiple metabolic syndrome in the ARIC cohort: Joint contribution of insulin, BMI, and WHRAnnals of Epidemiology, 1997